U.S. Household Products Stock News

BankUnited (BKU) is back in focus after quarterly results missed analyst expectations on both net interest income and EPS. Management highlighted record non interest bearing deposits, stronger fee income and better credit quality. See our latest analysis for BankUnited. At around $48.34, BankUnited’s recent 1 day share price return of 1.07% and 7 day share price return of 4.05% suggest some short term buying interest. The 1 year total shareholder return of 32.66% and 3 year total shareholder...

PG&E (NYSE: PCG) is reported to be a primary funder of "Wildfire Victims First", a coalition lobbying for wildfire bailout legislation while presenting utility-linked advocates as independent voices. Consumer Watchdog alleges the coalition is backed by PG&E and other utilities and that these ties were not clearly disclosed to the public or policymakers. The revelations raise questions about transparency in regulatory lobbying and how future wildfire liability rules might be shaped in favor...

In August 2026, Taboola.com Ltd. reported second-quarter 2026 results showing sales of US$476.83 million and net income of US$4.32 million, alongside six-month sales of US$943.22 million and net income of US$63.38 million, and issued revenue guidance of US$460 million–US$473 million for the third quarter and US$1.93 billion–US$1.96 billion for full-year 2026. The shift from net losses a year earlier to profits in both the quarter and first half, combined with quantified revenue guidance,...

Energizer Holdings (ENR) released third quarter and nine month results to June 30, 2026, with sales slightly higher than a year earlier, while net income and earnings per share moved sharply lower. See our latest analysis for Energizer Holdings. The recent third quarter earnings release, together with an update on the completed buyback program, comes after a strong 90 day share price return of 37.61%. However, the 1 year total shareholder return declined 13.45%, which suggests short term...

GE HealthCare Technologies (GEHC) has rolled out new ultrasound products that are drawing fresh attention to the stock. The LOGIQ e laptop systems and expanded breast imaging platform combine AI tools, portability and regulatory clearances. See our latest analysis for GE HealthCare Technologies. The LOGIQ e and Invenia ABUS launches come after a strong stretch for GE HealthCare Technologies, with a 30 day share price return of 16.8% and a 90 day share price return of 19.8% lifting the stock...

Pershing Square stock has had a strong run so far this year, yet the current valuation checks suggest the shares are not an obvious bargain. The market has pushed the price up quickly while the broader metrics still lean toward the stock screening as expensive. Pershing Square is up 68.7% year to date, which puts extra focus on whether the recent strength already reflects most of the good news in the price. The fund structure and concentrated portfolio can support earnings and asset growth...

OPKO Health (OPK) recently expanded its financing relationship with HealthCare Royalty by issuing an additional $125 million in senior secured notes tied to mazdutide royalties from Eli Lilly. This royalty backed deal provided OPKO with immediate, non dilutive capital. See our latest analysis for OPKO Health. The new financing comes after a period where OPKO Health’s 30 day share price return of 15.97% and 90 day share price return of 22.12% contrast with a 5 year total shareholder return...

In August 2026, Camtek Ltd. reported second-quarter 2026 results showing sales of US$133.24 million, up from US$123.32 million a year earlier, while net income and earnings per share from continuing operations declined year-on-year. At the same time, management issued third-quarter 2026 revenue guidance of US$158 million to US$160 million, implying an exceptional 20% sequential increase that contrasts sharply with the recent earnings pressure. With management now guiding to a sharp...

Cboe Global Markets stock has delivered a powerful run over the past five years, yet the current valuation checks suggest the shares are priced at a premium rather than standing out as a clear bargain. Cboe Global Markets has returned 144.0% over five years, which sets a high bar for what investors may reasonably expect from here. Recent growth efforts in areas like options, prediction markets and global clearing can support high expectations, while regulatory changes and business reshaping,...

In early August 2026, MACOM Technology Solutions Holdings reported third-quarter sales of US$342.24 million and net income of US$100.71 million, sharply higher than a year earlier, alongside significantly improved earnings per share. Over the first nine months of the fiscal year, the company shifted from a net loss to a net profit while also issuing stronger fourth-quarter revenue guidance of US$415 million to US$425 million, highlighting a marked turnaround in financial performance. We'll...

Cooling inflation, softer retail sales and housing strains are pulling markets in two directions, with income investors caught between rate expectations and worries about slower growth. That mix is putting more attention on real estate linked to everyday needs and steady rent checks. This article walks through three U.S. defensive, income focused real estate stocks exposed to these macro shifts and explains why they may deserve a closer look now. The stocks covered below are just a sample of...

Mirum Pharmaceuticals, Inc. reported past earnings for the second quarter and first half of 2026, disclosing a net loss of US$67.23 million for the quarter and a very large six‑month net loss, with basic loss per share from continuing operations rising to US$1.06 for the quarter and US$14.03 for the half year. The sharp widening of losses compared with the prior year highlights how Mirum’s cost base and investment intensity have increased relative to its current revenue scale. We’ll now...

Installed Building Products (IBP) is back in focus after second quarter results topped Wall Street expectations, with commercial installations and recent acquisitions helping offset softer single family residential demand, according to management commentary. See our latest analysis for Installed Building Products. Installed Building Products shares have pulled back in the short term, with the 1 day share price return down 2.38% and the year to date share price return down 10.18%. However, the...

XMax shares inched up about 2% into the weekend, yet the real jolt is in the earnings line. The stock barely moved, while Q2 net income and earnings per share swung sharply into profit, marking a clean break from last year’s losses. The key point is straightforward: XMax has shifted from fighting for survival on the income statement to reporting positive EPS, even as the market still prices the stock on a modest P/E next to peers. Is XMax trading at a genuine earnings reset discount, or has...

In August 2026, AbCellera Biologics Inc. reported positive Phase 2 results for its investigational menopause drug ABCL635 and completed a roughly US$200.00 million follow-on equity offering of common stock and pre-funded warrants. These developments, alongside a new collaboration with Vertex Pharmaceuticals on multispecific T‑cell engagers for autoimmune diseases, highlight AbCellera’s effort to expand its clinical pipeline while strengthening its funding base. We’ll now examine how the...

JetBlue Airways has delivered a 23.1% gain year to date and an 8.2% return over the last year, yet the stock still screens as cheap on several valuation checks after a 60.1% decline over the past five years. For investors looking at JetBlue Airways today, the question is whether the recent share price recovery is beginning to close that gap or if the stock still offers value. Over the past five years, JetBlue Airways shares have declined 60.1%, which suggests the market has already priced in...

Jefferson Capital stock has delivered a 35.5% return over the past year, yet the broader valuation checks point to a mixed picture rather than a clear bargain or clear premium. The 35.5% 1 year return suggests the market has re-rated Jefferson Capital positively. Investors now need to judge whether the current price still leaves enough room for a reasonable upside. Expansion into Latin America and growth in purchased portfolios can support expectations for future collections. At the same...

MacroGenics stock ticked up 3.4% to US$4.22 into the weekend, a modest relief move for a biotech that has been grinding through loss-making quarters and a choppy three month stretch. The headline from this earnings release is not the top line; it is the size of the earnings drag. MacroGenics reported a quarterly loss of US$69.6 million from ongoing operations and basic earnings per share of US$1.10 in the red. For anyone thinking beyond today’s small bounce, the real question is how long this...

In the second quarter of 2026, CareTrust REIT reported higher year-over-year revenue of US$161.35 million and net income of US$89 million, and subsequently raised its full-year 2026 net income guidance to about US$356 million–US$364 million, or US$1.53–US$1.56 per share. This combination of stronger earnings and upgraded guidance comes alongside record second-quarter investment activity at an average yield of 8.9%, highlighting how recent capital deployment is feeding directly into the...

StoneCo stock is coming off a difficult run, with the share price down 76.9% over the past five years, yet the current valuation checks still point to a company that screens cheap on several measures. That gap between weak long term returns and a strong value profile is what many investors are now trying to make sense of. The share price decline of 76.9% over five years shows that long term holders have taken a substantial hit, which often leaves the market cautious about assigning a higher...

In early August 2026, Kimberly-Clark reported slightly higher second-quarter sales of US$4,189 million but lower net income of US$345 million versus a year earlier, affirmed a US$1.28 quarterly dividend, completed its existing share repurchase plan, and earlier announced Suzana Blades will become Senior Vice President and General Counsel effective September 1, 2026. The company also introduced a patented alternative natural fiber program based on the hesperaloe plant, aiming to build a...

Oak Valley Bancorp slipped only 0.5% to about US$34 after its latest earnings, a muted reaction for a community bank that reported another quarter of solid net interest income. The short term story is a slight cooling in per share profit, with basic EPS at US$0.62 for the quarter, while the longer view still shows trailing 12 month earnings of US$2.84 per share and a dividend yield of 2.2%. The key point is margin. A net interest margin of 4.15% keeps Oak Valley Bancorp earning on its loan...

California ports are busy, tariffs are shifting trade routes, and clean energy projects are reshaping how goods move in and out of the country. That mix is creating fresh winners and new risks for companies tied to ports, rail and power systems. This article walks through three stocks from our U.S. Port-Linked Industrial & Clean Infrastructure Stocks screener that appear most exposed to the latest news and explains why that might matter for your portfolio. The stocks covered below are just a...

The market barely reacted to Copper Property CTL Pass Through Trust this week. The stock closed flat at $10.82, even as fresh Q2 numbers highlighted the real pressure point. The story is not the headline earnings per share; it is the squeeze on profitability. Over the last twelve months, net profit margin was 35.9% compared with 77.3% a year earlier. That, plus a large one off loss of $14.8m, has reduced earnings quality. For a yield focused real estate vehicle, that margin compression is the...